OTCPK:DTRK

Stock Analysis Report

Executive Summary

DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry.

Snowflake

Fundamentals

Excellent balance sheet with questionable track record.


Similar Companies

Share Price & News

How has DATATRAK International's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.2%

DTRK

-0.1%

US Healthcare Services

1.0%

US Market


1 Year Return

29.4%

DTRK

15.8%

US Healthcare Services

6.7%

US Market

Return vs Industry: DTRK exceeded the US Healthcare Services industry which returned 15.8% over the past year.

Return vs Market: DTRK exceeded the US Market which returned 6.7% over the past year.


Share holder returns

DTRKIndustryMarket
7 Day-0.2%-0.1%1.0%
30 Day-6.9%-0.9%-1.8%
90 Day-21.4%-7.5%-1.8%
1 Year29.4%29.4%16.0%15.8%9.1%6.7%
3 Year-28.5%-28.5%57.5%57.0%46.1%36.6%
5 Year1.9%1.9%52.5%51.4%66.9%48.6%

Price Volatility Vs. Market

How volatile is DATATRAK International's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is DATATRAK International undervalued based on future cash flows and its price relative to the stock market?

41.49x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Undervalued: Insufficient data to calculate DTRK's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate DTRK's fair value to establish if it is undervalued.


Price Based on Earnings

PE vs Industry: DTRK is good value based on its PE Ratio (41.5x) compared to the Healthcare Services industry average (53.4x).

PE vs Market: DTRK is poor value based on its PE Ratio (41.5x) compared to the US market (17.5x).


Price Based on Expected Growth

Low PEG Ratio: Insufficient data to calculate DTRK's PEG Ratio to determine if it is good value.


Price Based on Value of Assets

PB vs Industry: DTRK is overvalued based on its PB Ratio (14.8x) compared to the US Healthcare Services industry average (3.5x).


Next Steps

Future Growth

How is DATATRAK International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

-2.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Earnings vs Savings Rate: DTRK's earnings are forecast to decline over the next 3 years (-2.3% per year).

Earnings vs Market: DTRK's earnings are forecast to decline over the next 3 years (-2.3% per year).

High Growth Earnings: DTRK's earnings are forecast to decline over the next 3 years.

Revenue vs Market: Insufficient data to determine if DTRK's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if DTRK's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Estimates


Future Return on Equity

High Future ROE: Insufficient data to determine if DTRK's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has DATATRAK International performed over the past 5 years?

55.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: DTRK has become profitable over the past 5 years, growing earnings by 55.7% per year.

Accelerating Growth: DTRK's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: DTRK had negative earnings growth (-35.8%) over the past year, making it difficult to compare to the Healthcare Services industry average (3.3%).


Return on Equity

High ROE: DTRK's Return on Equity (35.4%) is considered high.


Return on Assets

ROA vs Industry: DTRK's Return on Assets is below or equal to the Healthcare Services industry average last year.


Return on Capital Employed

ROCE Improving: DTRK's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is DATATRAK International's financial position?


Financial Position Analysis

Short Term Liabilities: DTRK's short term assets ($4.9M) exceeds its short term liabilities ($1.1M)

Long Term Liabilities: DTRK's short term assets (4.9M) do not cover its long term liabilities (6.9M)


Debt to Equity History and Analysis

Debt Level: DTRK is debt free.

Reducing Debt: DTRK had no debt 5 years ago.

Debt Coverage: DTRK has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: DTRK has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: DTRK has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if DTRK's debt is covered by short term assets.


Next Steps

Dividend

What is DATATRAK International's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.1%forecastin3Yearsn/a

Current dividend yield vs market & industry


Dividend Yield and Payments Analysis

Notable Dividend: Unable to evaluate DTRK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate DTRK's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if DTRK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DTRK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DTRK's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of DATATRAK International's salary, the management and board of directors tenure and is there insider trading?

3.4yrs

Average board tenure


CEO

Jim Ward (58yo)

3.4yrs

Tenure

US$140,000

Compensation

Mr. Jim Bob Ward, MS has been the Chief Executive Officer and President of DATATRAK International, Inc. since May 23, 2016 and served as its Interim Chief Executive Officer from February 23, 2016 to May 23 ...


Board Age and Tenure

3.4yrs

Average Tenure

Experienced Board: DTRK's board of directors are considered experienced (3.4 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Management Team

  • Jim Ward (58yo)

    CEO, President & Director

    • Tenure: 3.4yrs
    • Compensation: US$140.00k
  • Tim Lyons

    Vice President of Product Development & Operations

    • Tenure: 0yrs
  • Scott DeMell

    Vice President of Sales

    • Tenure: 4.1yrs

Board Members

  • Jack Jacobs (74yo)

    Director

    • Tenure: 3.8yrs
  • Jim Ward (58yo)

    CEO, President & Director

    • Tenure: 3.4yrs
    • Compensation: US$140.00k
  • Eric Wilhelm

    Independent Director

    • Tenure: 3.2yrs
  • Alex Tabatabai

    Chairman of the Board

    • Tenure: 3.7yrs
  • Rizvan Mirza

    Director

    • Tenure: 0.8yrs
  • Behnam Tabatabai

    Director

    • Tenure: 0.8yrs

Company Information

DATATRAK International, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: DATATRAK International, Inc.
  • Ticker: DTRK
  • Exchange: OTCPK
  • Founded: 1991
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$12.973m
  • Shares outstanding: 2.36m
  • Website: https://www.datatrak.com

Number of Employees


Location

  • DATATRAK International, Inc.
  • 5900 Landerbrook Drive
  • Suite 170
  • Mayfield Heights
  • Ohio
  • 44124
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
DTRKOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 1996

Biography

DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry. The company offers DATATRAK ONE Unified Experienc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/14 01:09
End of Day Share Price2019/10/10 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. ALL RIGHTS RESERVED.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Copyright © 2018, Standard & Poor’s Financial Services LLC. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. (2018)